Estimation of taxol influence on changes in tubulin and vimentin systems in K-562 and HL-60 cell lines by immunofluorescence microscopy

Neoplasma

Volumn 52, Issue 3, 2005, Pages 193-198

  Grzanka, A ^a   Grzanka, D ^a   Orlikowska, M ^a   Zuryn A ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Apoptosis; HL 60 cells; Immunofluorescence microscopy; K 562 cells; Taxol; Tubulin; Vimentin

Indexed keywords

CYTOSKELETON PROTEIN; PACLITAXEL; TUBULIN; VIMENTIN;

APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY;

EID: 20144382213     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ASUMENDI A, ANDOLLO N, BOYANO MD, HILARIO E, PEREZ-YARZA G et al. The role of cleavage of cell structures during apoptosis. Cell Mol Biol 2000; 46: 1-11.
2. BELL PB, SAFIEJKO-MROCZKA B. Improved methods for preserving macromolecular structures and visualizing them by fluorescence and scanning electron microscopy. Scanning Microsc 1995; 9: 843-860.
3. BONANNO E, RUZITTU M, CARLA EC, MONTINARI MR, PAGLIARA P et al. Cell shape and organelle modification in apoptotic U937 cells. Eur J Histochem 2000; 44: 237-246.
4. BONNETERRE J, TUBIANA-HULIN M, CATIMEL G. Paclitaxel, epirubicin and cyclophosphamide combination in first-line treatment of metastatic breast cancer: a dose escalation study. Oncology 2004; 66: 185-191.
5. BROWN WJ, NORWOOD CF, SMITH RG, SNELL WJ et al. Development of capping ability during differentiation of HL-60 human promyelocytic leukemia cells. J Cell Physiol 1981; 106: 127-136.
6. BURSCH W, HOCHEGGER K, TOROK L, MARIAN B, ELLINGER A et al. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci 2000; 113: 1189-1198.
7. CHEN Z, NAITO M, MASHIMA T, TSURURO T. Activation of actin-cleavable interleukin 1beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent induced apoptosis in ovarian carcinoma cells. Cancer Res 1996; 56: 5224-5229.
8. CHANG L, GOLDMAN RD. Intermediate filaments mediate cytoskeletal crosstalk. Nat Rev Mol Cell Biol 2004; 5: 601-613.
9. CHU JJ, CHEN KD, LIN YL, FEI CY, CHIANG AS et al. Taxol induces concomitant hyperphosphorylation and reorganization of vimentin intermediate filaments in 9L rat brain tumor cells. J Cell Biochem 1998; 68: 472-483.
10. COTTER TG, LENNON SV, GLYNN JM, GREEN DR. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 1992; 52: 997-1005.
11. DELLAGI K, BROUET JC. Alteration of vimentin intermediate filaments expression during differentiation of HL60 and U937 human leukemic cell lines. Leuk Res 1984; 8: 611-616.
12. DRABEROVA E, DRABER P. A microtubule-interacting protein involved in coalignment of vimentin intermediate filaments with microtubules. J Cell Sci 1993; 106: 1263-1273.
13. EINZIG AI, HOCHSTER H, WIERNIK PH, TRUMP DL, DUTCHER JP et al. A phase II study of taxol in patients with malignant melanoma. Invest New Drugs 1991; 9: 59-64.
14. GANGEMI RM, TISO M, MARCHETTI C, SEVERI AB, FABBI M. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother Pharmacol 1995; 36: 385-392.
15. GRZANKA A. Actin distribution patterns in HL-60 leukemia cells treated with etoposide. Acta Histochem 2000; 103: 453-464.
16. GRZANKA A, GRZANKA D. The influence of etoposide on the distribution of tubulin in human leukemia cell line HL-60. Med Sci Monit 2003; 9: BR66-BR69.
17. GRZANKA A, GRZANKA D, ORLIKOWSKA M. Cytoskeletal reorganization during process of apoptosis induced by cytostatic drugs in K-562 and HL-60 leukemia cell lines. Biochem Pharmacol 2003; 66: 1611-1617.
18. HASS R, BARTELS H, TOPLEY N, HADAM M, KOHLER L et al. TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. Eur J Cell Biol 1989; 48: 282-293.
19. HASSAN Z, FADEEL B, ZHIVOTOVSKY B, HELLSTROM-LINDBERG E. Two pathways of apoptosis induced with all trans retinoic acid and etoposide in the myeloid cell line P39. Exp Hematol 1999; 27: 1322-1329.
20. HOLMES FA, WALTERS RS, THERIAULT RL, FORMAN AD, NEWTON LK et al. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 1991; 83: 1797-1805.
21. HOLTON RA, SOMOZA C, KIM HB, LIANG F, BIEDIGER RJ et al. First total synthesis of taxol. J Am Chem Soc 1994; 116: 1597-1600.
22. KELLY RB. Microtubules, membrane traffic, and cell organization. Cell 1990; 61: 5-7.
23. LEUNG MF, LIN TS, SARTORELLI AC. Changes in actin and actin-binding proteins during the differentiation of HL-60 leukemia cells. Cancer Res 1992; 52: 3063-3066.
24. LEUNG MF, SOKOLOSKI JA, SARTORELLI AC. Changes in microtubules, microtubule-associated proteins, and intermediate filaments during the differentiation of HL-60 leukemia cells. Cancer Res 1992; 52: 949-954.
25. LEVEE MG, DABROWSKA MI, LELLI JL, HINSHAW DB. Actin polymerization and depolymerization during apoptosis in HL-60 cells. Am J Physiol 1996; 271: C1981-1992.
26. LONG BH, FAIRCHILD CR. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res 1994; 54: 4355-4361.
27. MASHIMA T, NAITO M, FUJITA N, NOGUCHI K, TSURUO T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16 induced U937 apoptosis. Biochem Biophys Res Commun 1995; 217: 1185-1192.
28. McGUIRE WP, ROWINSKY EK, ROSENSHEIN NB, GRUMBINE FC, ETTINGER DS et al. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989; 111: 273-279.
29. MEYER WH, HOWARD TH. Actin polymerization and its relationship to locomotion and chemokinetic response in maturing human promyelocytic leukemia cells. Blood 1987; 70: 363-367.
30. MULLER K, DULKU S, HARDWICK SJ, SKEPPER JN, MITCHINSON MJ. Changes in vimentin in human macrophages during apoptosis induced by oxidised low density lipoprotein. Atherosclerosis 2001; 156: 133-147.
31. NGAI J, CAPETANAKI YG, LAZARIDES E. Differentiation of murine erythroleukemia cells results in the rapid repression of vimentin gene expression. J Cell Biol 1984; 99: 306-314.
32. NICOLAOU KC, YANG Z, LIU JJ, UENO H, NANTERMET PG et al. Total synthesis of taxol. Nature 1994; 367: 630-634.
33. OLINS AL, HERRMANN H, LICHTER P, OLINS DE. Retinoic acid differentiation of HL-60 cells promotes cytoskeletal polarization. Exp Cell Res 2000; 254: 130-142.
34. OLINS AL, OLINS DE. Cytoskeletal influences on nuclear shape in granulocytic HL-60 cells. BMC Cell Biol 2004; 5: 30.
35. REED E, KOHN EC, SAROSY G, DABHOLKAR M, DAVIS P et al. Paclitaxel, cisplatin, and cyclophosphamide in human ovarian cancer: molecular rationale and early clinical results. Semin Oncol 1995; 22: 90-96.
36. RODI DJ, JANES RW, SANGANEE HJ, HOLTON RA, WALLACE BA et al. Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. J Mol Biol 1999; 285: 197-203.
37. ROWINSKY EK, BURKE PJ, KARP JE, TUCKER RW, ETTINGER DS et al. Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Res 1989; 49:4640-4647.
38. ROWINSKY EK, CAZENAVE LA, DONEHOWER RC. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 1990; 82: 1247-1259.
39. SAWICKI S. Elementary statistics for physicians. Warsaw: Medical Publishers PZWL, 1982 [in Polish].
40. SCHIFF PB, FANT J, HORWITZ SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-667.
41. SHANG X, SHIONO Y, FUJITA Y, OKA S, YAMAZAKI Y. Synergistic enhancement of apoptosis by DNA and cytoskeleton-damaging agents: a basis for combination chemotherapy of cancer. Anticancer Res 2001; 21: 2585-2589.
42. SVITKINA TM, VERKHOVSKY AB, BORISY GG. Plectin side-arms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J Cell Biol 1996; 135: 991-1007.
43. THOMPSON WC, WILSON L, PURICH DL. Taxol induces microtubule assembly at low temperature. Cell Motil 1981; 1: 445-454.
44. TREVOR KT, McGUIRE JG, LEONOVA EV. Association of vimentin intermediate filaments with the centrosome. J Cell Sci 1995; 108: 343-356.
45. UEDA N, WALKER PD, HSU SM, SHAH S. Activation of a 15-kDa endonuclease in hypoxia/reoxygenation injury without morphologic features of apoptosis. Proc Natl Acad Sci USA 1995; 92: 7202-7206.
46. VASILIEV JM. Polarization of pseudopodial activities: cytoskeletal mechanisms. J Cell Sci 1991; 98: 1-4.
47. WIERNIK PH, SCHWARTZ EL, EINZIG A, STRAUMAN JJ, LIPTON RB et al. Phase I trial of taxol given as a 24 hour infusion every 21 days: responses observed in metastatic melanoma. J Clin Oncol 1987; 5: 1232-1239.